Understanding Your PVNH Diagnosis
At a Glance
A PVNH diagnosis shows that some brain cells stayed beside the brain’s fluid-filled spaces instead of reaching the outer brain layer. MRI findings alone cannot predict the future; seizures, learning, and development vary, so genetics and the full clinical picture matter.
Receiving a diagnosis of Periventricular Nodular Heterotopia (PVNH) can feel overwhelming, especially when the name itself sounds so complex. In the simplest terms, PVNH is a condition where some of the brain’s “gray matter”—the cells responsible for processing information—did not travel to their intended destination during fetal development [1]. Instead of reaching the outer layer of the brain (the cortex), these cells stayed behind and formed small clumps or “nodules” along the walls of the fluid-filled spaces in the brain called ventricles [2][3].
While this is a permanent structural change in the brain, it is important to know that the appearance of PVNH on an MRI does not automatically predict a person’s future [4]. People with PVNH have a wide range of experiences: some lead typical lives with no medical issues, while others may face challenges like seizures or learning differences [5][6].
How the Brain Develops in PVNH
During pregnancy, a baby’s brain undergoes a remarkable journey. Brain cells are born near the center of the brain and must “migrate” or crawl outward to form the cerebral cortex—the wrinkled outer layer used for thinking and movement. PVNH is classified as a malformation of cortical development (a group of disorders where the brain’s cortex does not form typically), specifically a disorder of neuronal migration [1][2].
In PVNH, this migration process is interrupted. Because of genetic factors or other disruptions, some neurons never start their journey or get stuck along the way. These “misplaced” neurons (called ectopic gray matter) then clump together into the nodules seen on an MRI [3].
What an MRI Can and Cannot Tell You
Seeing nodules on an MRI provides a “map” of the brain’s structure, but it is not a crystal ball for how the brain functions.
- The Spectrum of Outcomes: Outcomes vary wildly. Many individuals have typical cognition and never develop epilepsy [5][7]. Others may experience mild to moderate developmental delays or seizures that are easy to manage with medication [6].
- Seizure Risk: Having PVNH does not mean you will definitely have epilepsy. In some groups of patients, seizures did not start until their late teens or early twenties, and some never had them at all [5].
- Complexity Matters: Doctors often look at whether the PVNH is “isolated” (meaning only nodules are present) or if there are associated malformations (meaning there are other brain changes, like a smaller-than-typical cerebellum or changes in the cortex). PVNH combined with other malformations is sometimes associated with a higher likelihood of seizures or developmental needs [8][9][4].
The Role of Genetics
In many cases, PVNH is caused by a change in a gene. Understanding the genetic cause can help your doctors better understand what to expect.
- FLNA Gene: This is the most common known genetic cause in particular familial or bilateral patterns, especially in females. It often results in nodules on both sides of the brain (bilateral). While it can cause epilepsy, many people with this gene change have typical intelligence and live standard lives [10][5]. Because this gene also affects other parts of the body, doctors may recommend checking the heart and blood vessels if this gene is implicated [11][12].
- Other Genes: Other genes (such as ARFGEF2, MAP1B, or NEDD4L) are also linked to PVNH. These can sometimes be associated with more significant developmental delays or seizures that start earlier in childhood [13][14][15].
- Undiagnosed Cases: Because mild PVNH may cause no symptoms at all, many people likely have the condition and never know it [16]. Often, a parent is only diagnosed after their child receives a diagnosis and the whole family is screened [5].
Navigating the Diagnosis
It is normal to feel anxious when looking at a “misplaced” part of the brain on a screen. However, the brain is remarkably adaptable. Recent functional studies have even shown that these nodules show variable network participation and can be active in the brain’s networks, rather than simply being inactive tissue [17]. Your care team will focus on you or your child as a whole person—treating symptoms if they arise, rather than just treating an image on a scan.
Common questions in this guide
What is periventricular nodular heterotopia, and what does it mean for my health?
Can an MRI showing PVNH predict whether I will have seizures or learning problems?
Why does it matter whether PVNH is isolated or associated with other brain changes?
What genetic tests may be used to investigate PVNH?
Can PVNH run in families?
Can PVNH affect the heart or blood vessels?
Get notified when new evidence is published on Periventricular nodular heterotopia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Diagnostic work-up in malformations of cortical development.
Rijckmans E, Stouffs K, Jansen AC
Developmental medicine and child neurology 2024; (66(8)):974-989 doi:10.1111/dmcn.15882.
PMID: 38394064 - 2
Grey matter heterotopia subtypes show specific morpho-electric signatures and network dynamics.
Vermoyal JC, Hardy D, Goirand-Lopez L, et al.
Brain : a journal of neurology 2024; (147(3)):996-1010 doi:10.1093/brain/awad318.
PMID: 37724593 - 3
Malformations of Cortical Development: From Postnatal to Fetal Imaging.
Lerman-Sagie T, Leibovitz Z
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43(5)):611-8 doi:10.1017/cjn.2016.271.
PMID: 27670206 - 4
Magnetic resonance imaging features of isolated periventricular heterotopia in pediatric epilepsy: a comparative study
Tittle BJ, Maheshwari M, Marashly A
Epileptic disorders : international epilepsy journal with videotape 2022; (24(5)):795-802 doi:10.1684/epd.2022.1450.
PMID: 35792848 - 5
47 patients with FLNA associated periventricular nodular heterotopia.
Lange M, Kasper B, Bohring A, et al.
Orphanet journal of rare diseases 2015; (10()):134 doi:10.1186/s13023-015-0331-9.
PMID: 26471271 - 6
Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation.
Hoogwijs I, Mandelstam SA, McGillivray G, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (60()):78-85 doi:10.1016/j.ejpn.2025.12.004.
PMID: 41468712 - 7
Phenotypic and imaging features of FLNA-negative patients with bilateral periventricular nodular heterotopia and epilepsy.
Fallil Z, Pardoe H, Bachman R, et al.
Epilepsy & behavior : E&B 2015; (51()):321-7.
PMID: 26340046 - 8
Sporadic periventricular nodular heterotopia: Classification, phenotype and correlation with Filamin A mutations.
Liu W, Yan B, An D, et al.
Epilepsy research 2017; (133()):33-40 doi:10.1016/j.eplepsyres.2017.03.005.
PMID: 28411558 - 9
The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia.
Paliotti K, Dassi C, Berrahmoune S, et al.
Journal of neurology 2023; (270(8)):3934-3945 doi:10.1007/s00415-023-11724-z.
PMID: 37119372 - 10
A familial case of diffuse periventricular nodular heterotopia identified prenatally: Filamin A defect as the probable cause.
Neves MT, Borges AL, Martins G, et al.
Radiology case reports 2024; (19(11)):5393-5398 doi:10.1016/j.radcr.2024.07.190.
PMID: 39285959 - 11
Phenotypic manifestations in FLNA-related periventricular nodular heterotopia: a case report and review of the literature.
Loft Nagel J, Jønch AE, Nguyen NTTN, Bygum A
BMJ case reports 2022; (15(4)) doi:10.1136/bcr-2021-247268.
PMID: 35414575 - 12
"Phenotypic and genotypic insights, counseling strategies, and follow-up in 24 individuals with filamin a deficiency: findings from a retrospective cohort study".
Rijckmans E, De Strooper L, Keymolen K, et al.
Acta neurologica Belgica 2025; (125(5)):1347-1356 doi:10.1007/s13760-025-02858-0.
PMID: 40758172 - 13
ARFGEF2-Related Periventricular Nodular Heterotopia: A Case Report and Literature Review.
Andreoli L, Caputo D, Doniselli FM, et al.
NeuroSci 2026; (7(3)) doi:10.3390/neurosci7030063.
PMID: 42200925 - 14
MAP1B Variants Disrupt Neuronal Migration: Insights From Three Novel Families.
Archer J, Edwards M, Macdougall T, et al.
Clinical genetics 2026; (109(3)):558-563 doi:10.1111/cge.70059.
PMID: 40874586 - 15
Recurrent NEDD4L Variant in Periventricular Nodular Heterotopia, Polymicrogyria and Syndactyly.
Stouffs K, Verloo P, Brock S, et al.
Frontiers in genetics 2020; (11()):26 doi:10.3389/fgene.2020.00026.
PMID: 32117442 - 16
Three Generations of FLNA-Associated Periventricular Nodular Heterotopia.
Eisenbiegler GE, Brown SA
Case reports in neurology 2021; (13(3)):777-781 doi:10.1159/000519507.
PMID: 35082648 - 17
Involved but not essential: cognitive activity in periventricular nodules and neuropsychological outcomes following their ablation.
Modiano YA, Woolnough O, McCormack RM, et al.
Journal of neurosurgery 2025; (143(1)):24-37 doi:10.3171/2024.10.JNS241541.
PMID: 40020237
This page is for informational purposes only and does not constitute medical advice. A neurologist or genetics professional should interpret your or your child’s MRI, symptoms, and test results.